Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3057% below fair value
$10.18+0.01 (+0.10%)
Close on Nov 20, 2026Market cap $179.12MP/E 10.1Yield –
Natures Sunshine Products net income
Net income is the profit left for shareholders after every expense, interest and tax.
Natures Sunshine Products's net income for the twelve months ending Jun 30, 2026 was $18.10M, up 28.3% year over year. For fiscal 2025 it was $19.52M, up 153.7% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.52M | +153.7% |
| FY2024 | Dec 31, 2024 | $7.70M | -49.0% |
| FY2023 | Dec 31, 2023 | $15.08M | – |
| FY2022 | Dec 31, 2022 | -$390.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.54M | -33.7% |
| Q1 FY2026 | Mar 31, 2026 | $5.12M | +7.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.11M | – |
| Q3 FY2025 | Sep 30, 2025 | $5.33M | +22.7% |
| Q2 FY2025 | Jun 30, 2025 | $5.33M | +295.3% |
| Q1 FY2025 | Mar 31, 2025 | $4.75M | +104.5% |
| Q4 FY2024 | Dec 31, 2024 | -$321.00K | -103.6% |
| Q3 FY2024 | Sep 30, 2024 | $4.35M | +53.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.35M | -44.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.32M | +169.9% |
| Q4 FY2023 | Dec 31, 2023 | $8.96M | +358.6% |
| Q3 FY2023 | Sep 30, 2023 | $2.83M | +3046.7% |
| Q2 FY2023 | Jun 30, 2023 | $2.42M | +369.4% |
| Q1 FY2023 | Mar 31, 2023 | $860.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $1.95M | -59.8% |
| Q3 FY2022 | Sep 30, 2022 | $90.00K | -98.6% |
| Q2 FY2022 | Jun 30, 2022 | $516.00K | -87.2% |
| Q1 FY2022 | Mar 31, 2022 | -$2.95M | -143.7% |
| Q3 FY2021 | Sep 30, 2021 | $4.86M | -15.6% |
| Q2 FY2021 | Jun 30, 2021 | $6.54M | +120.8% |
| Q1 FY2021 | Mar 31, 2021 | $4.02M | +204.9% |
| Q3 FY2020 | Sep 30, 2020 | $6.76M | +151.2% |
| Q2 FY2020 | Jun 30, 2020 | $5.75M | +227.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.96M | +97.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.32M | +1865.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.69M | +10.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.76M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.50M | -62.0% |
| Q2 FY2018 | Jun 30, 2018 | $67.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $2.44M | – |
| Q2 FY2017 | Jun 30, 2017 | -$187.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $3.94M | – |
See a number that looks wrong?